Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or Refractory CD37+ Hematologic Malignancies

Matthew J. Frigault, Yi-Bin Chen, Kathleen M.E. Gallagher, Nora K. Horick, Areej El-Jawahri, Irene Scarfò, Marc Wehrli, Lu Huang, Keagan Casey, Daniella Cook, Thomas Spitzer, Steven McAfee, Frederic I. Preffer, Myriam Armant, Kit L. Shaw, Heather Daley, Sarah Nikiforow, Jerome Ritz, Marcela V. Maus

Blood (2021) 138 (Supplement 1): 653.

https://doi.org/10.1182/blood-2021-146236

Published: 2021

Journal Articles

Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 1431.

https://doi.org/10.1182/blood-2018-99-115031

Published: 2018

Journal Articles

Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas

Irene Scarfò, Maria Ormhøj, Matthew J. Frigault, Ana P. Castano, Selena Lorrey, Amanda A. Bouffard, Alexandria van Scoyk, Scott J. Rodig, Alexandra J. Shay, Jon C. Aster, Frederic I. Preffer, David M. Weinstock, Marcela V. Maus

Blood (2018) 132 (14): 1495–1506.

https://doi.org/10.1182/blood-2018-04-842708

Published: 2018

Includes: Supplemental data

Journal Articles

Urate Oxidase (Rasburicase) to Inhibit Graft Versus Host Disease (GVHD) After Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation (HCT).

Andrew M. Brunner, MD, Thomas R. Spitzer, MD, Yi-Bin A. Chen, MD, Erin Coughlin, Steven L. McAfee, MD, Karen K. Ballen, MD, Eyal C. Attar, MD, Martin Caron, Frederic I. Preffer, PhD, Beow Y Yeap, ScD, Bimalangshu R Dey, MD

Blood (2012) 120 (21): 3063.

https://doi.org/10.1182/blood.V120.21.3063.3063

Published: 2012

Journal Articles

Quantitative Flow Cytometric Assessment of CD36 (Platelet Glycoprotein IV) Expression on Monocytes and Platelets: Assay Development, Role in Plasmodium falciparum Risk Assessment, and Relationship to Sickle Hemoglobin.

Christine M. Cserti, MD, Songyi Xu, Robert Sutherland, PhD, Rakesh Nayar, Marciano Reis, MD, Michelle E. Dorn, Robert O. Quagliaroli, John D. Sullivan, Frederic I. Preffer, PhD, Walter H. Dzik, MD

Blood (2007) 110 (11): 3857.

https://doi.org/10.1182/blood.V110.11.3857.3857

Published: 2007

Journal Articles

Donor Specific Unresponsiveness Develops Following Loss of Chimerism in Recipients of Haploidentical Combined Bone Marrow/Kidney Transplantation but Not in Recipients of Bone Marrow Transplant Alone.

Giovanna Andreola, Juanita Shaffer, A. Benedict Cosimi, Tatsuo Kawai, Pete Cotter, Bimalangshu R. Dey, Nina Tolkoff-Rubin, Frederic I. Preffer, Susan Saidman, Kristin Kattleman, David H. Sachs, Thomas R. Spitzer, Megan Sykes

Blood (2006) 108 (11): 3103.

https://doi.org/10.1182/blood.V108.11.3103.3103

Published: 2006

Journal Articles

Minimal HLA Disparity and KIR Ligand Compatibility in Host Versus Graft Direction May Facilitate Donor Engraftment Following In Vivo and Ex Vivo T Cell Depleted (TCD) Nonmyeloablative Haploidentical Stem Cell Transplantation for Hematologic Malignancies.

Andrew J. Yee, MD, Thomas R. Spitzer, MD, Susan L. Saidman, PhD, Juanita Shaffer, Karen A. Power, Steven L. McAfee, MD, Karen K. Ballen, MD, Eyal C. Attar, MD, Frederic I. Preffer, PhD, Megan Sykes, MD, Bimalangshu R. Dey, MD

Blood (2005) 106 (11): 3668.

https://doi.org/10.1182/blood.V106.11.3668.3668

Published: 2005

NARROW

Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or Refractory CD37+ Hematologic Malignancies

Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Myeloid Leukemia

Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas

Urate Oxidase (Rasburicase) to Inhibit Graft Versus Host Disease (GVHD) After Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation (HCT).

Quantitative Flow Cytometric Assessment of CD36 (Platelet Glycoprotein IV) Expression on Monocytes and Platelets: Assay Development, Role in Plasmodium falciparum Risk Assessment, and Relationship to Sickle Hemoglobin.

Donor Specific Unresponsiveness Develops Following Loss of Chimerism in Recipients of Haploidentical Combined Bone Marrow/Kidney Transplantation but Not in Recipients of Bone Marrow Transplant Alone.

Minimal HLA Disparity and KIR Ligand Compatibility in Host Versus Graft Direction May Facilitate Donor Engraftment Following In Vivo and Ex Vivo T Cell Depleted (TCD) Nonmyeloablative Haploidentical Stem Cell Transplantation for Hematologic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Phase 1 Study of CD37-Directed CAR T Cells in Patients with Relapsed or Refractory CD37+ Hematologic Malignancies

Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Myeloid Leukemia

Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas

Urate Oxidase (Rasburicase) to Inhibit Graft Versus Host Disease (GVHD) After Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation (HCT).

Quantitative Flow Cytometric Assessment of CD36 (Platelet Glycoprotein IV) Expression on Monocytes and Platelets: Assay Development, Role in Plasmodium falciparum Risk Assessment, and Relationship to Sickle Hemoglobin.

Donor Specific Unresponsiveness Develops Following Loss of Chimerism in Recipients of Haploidentical Combined Bone Marrow/Kidney Transplantation but Not in Recipients of Bone Marrow Transplant Alone.

Minimal HLA Disparity and KIR Ligand Compatibility in Host Versus Graft Direction May Facilitate Donor Engraftment Following In Vivo and Ex Vivo T Cell Depleted (TCD) Nonmyeloablative Haploidentical Stem Cell Transplantation for Hematologic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only